Clinical Trials
Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine Candidate
Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced positive...
Clinical Trials
Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
Eli Lilly and Company and Incyte announced results from an additional cohort of 101 adult patients from the COV-BARRIER trial. In this sub-study, patients with...
Clinical Trials
Genoskin launches the ISR platform: the first human skin ex vivo platform to study injection site reactions ahead of clinical trials
Genoskin announces the launch of the ISR platform®, a new pre-clinical toolbox designed to study injection site reactions (ISR) in humans ahead of clinical trials....
Clinical Trials
UPS Healthcare Partners with THREAD to Deliver First Decentralized Clinical Trial Platform
UPS Healthcare's clinical trial logistics unit, Marken, and THREAD, an innovative decentralized clinical trial technology provider, announced a partnership to bring the first ever, unified,...
Clinical Trials
Alvotech Initiates Clinical Studies for AVT04, A Proposed Biosimilar to Stelara
Alvotech, the Iceland-based biosimilar company, announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT04,...
Clinical Trials
Zydus applies to the DCGI for EUA to launch ZyCoV-D, the world’s first Plasmid DNA vaccine for COVID-19
Zydus Cadila announced that the company has applied for EUA to the office of Drug Controller General of India (DCGI) for ZyCoV-D -its Plasmid DNA...
Clinical Trials
Bharat Biotech concludes final analysis for Covaxin efficacy from phase 3 clinical trials
Bharat Biotech, a global leader in vaccine development and innovation, announced safety and efficacy analysis data from Phase III clinical trials of COVAXIN®, a whole...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.